CVX vs UNH: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and UnitedHealth Group Incorporated β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Chevron Corporation Β· Energy
$175.91
-3.4% upside to fair value
Grade D
VS
UnitedHealth Group Incorporated Β· Healthcare
$423.38
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
UNH trades at a lower forward P/E
(27.2x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
CVX |
UNH |
| Current Price |
$175.91 |
$423.38 |
| Fair Value Estimate |
$169.96 |
$613.90 |
| Upside to Fair Value |
-3.4%
|
+45.0%
|
| Market Cap |
$350.3B |
$384.5B |
| Forward P/E |
30.4x
|
27.2x
|
| EV / EBITDA |
9.4x
|
13.8x
|
| Price / Sales |
1.9x
|
0.8x
|
| Price / FCF |
26.2x
|
19.6x
|
| Revenue Growth YoY |
+3.2%
|
+0.4%
|
| Gross Margin |
25.4%
|
18.8%
|
| Operating Margin |
8.4%
|
4.2%
|
| Return on Equity |
6.2%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.82%
|
5.12%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Chevron Corporation operates as a leading integrated oil and gas company within the energy sector, demonstrating medium business quality with a stable competitive position but facing earnings pressure as evidenced by a 36.9% decline in earnings in the most recent quarter. The stock trades at a premium valuation with a P/E trailing and forward of 30.38, EV/EBITDA of 9.41, and a P/FCF of 26.2, reflβ¦
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by aβ¦
Accumulation Zones
| Metric |
CVX |
UNH |
| Zone Low |
$127.47 |
$460.42 |
| Zone High |
$144.47 |
$521.81 |
| In Buy Zone? |
No
|
Yes
|